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a  b  s  t  r  a  c  t
Aim:  To show  three  patients  with  soft  tissue  sarcomas  of  distal  extremities  conservatively  treated
after  tumor-board  discussion,  involving  margin-free  surgery,  exclusive  intraoperative  radiotherapy,  and
immediate  reconstruction.
Background: Current  guidelines  show  clear  and  robust  recommendations  regarding  the  composition  of  the
treatment  of sarcomas  of  extremities.  However,  little  evidence  exists  regarding  the  application  of  these
treatments  depending  on the  location  of  the  primary  neoplasia.  Tumors  that  affect  the  distal  extremities
present  different  challenges  and make  multidisciplinary  discussions  desirable.
Methods/Results:  We  reported  3 patients  who  were  approached  with  a conservative  intention,  after  tumor
board recomendation.  The  goals  from  the  treatment  performed  were  aesthetic  and  functional  preserva-
tion,  while  enruring  locoregional  control.  We  had  wound  healing  complications  in  2  of  the  cases,  requiring
additional  reconstruction  measures.  Patients  are  followed  up  for 24,  20  and  10  months;  local  control  is
100%,  and functional  preservation  is  100%.
Conclusions:  Despite  being  a small  series,  it was  sufficient  to  illustrate  successful  multidisciplinary  plan-
ning,  generating  a therapeutic  result  with  improved  quality  of  life  for patients  who  had  an  initial  indication
for  extremity  amputation.







Soft tissue sarcomas (STS) are a heterogeneous group of mes-
enchymal tumors.1–3 Although they may  appear in any location,
most cases arise in the extremities.4–6 In the 1980s and 90 s, several
seminal studies validated a conservative multimodality approach,
mainly composed by limb sparing surgery followed by radiotherapy
(RT), with or without chemotherapy. Similar survival rates were
observed when comparing the multimodality conservative man-
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espite a slight increase in local recurrence rates.7–12
Due to anatomic reasons, distal extremity STS may  infiltrate ten-
ons, joints, nerves, and bones at early stages. In general, patients
ith distal tumors were underrepresented in the majority of the
tudies. Only a randomized study conducted at Memorial Sloan
ettering Cancer Center12 (with a 20-year update13) addressing
he efficacy of post-operative external-beam RT versus observa-
ion characterized the outcomes of a subset of distal extremity
atients (4 and 8% of distal upper, and 30 and 18% of distal lower,
espectively), but this variable (distal extremity location) was not
nalyzed as a predictor of the main study endpoints (toxicity, sur-
ival, and limb functionality).
In fact, amputations of distal extremities STS were often
ndicated due to difficulties in achieving free three-dimensional
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tions. In most cases, the reasons that had been used to justify a
non-conservative approach to treat patients with distal extremity
STS are based on some major points: (1) difficulties in achieving
adequate macroscopic surgical and microscopic pathological mar-
gins; (2) even with microscopic free margins, marginal resections
are clearly associated with a high risk of local recurrence; (3) resec-
tions performed for distal extremity STS are generally associated
with aesthetic and functional losses and attempts to involve major
reconstructions, with a high risk of post-operative complications14
and losses of flaps/grafts15 and (4) external-beam RT on distal
extremities is worse tolerated by the inherent sensitivity of healthy
tissues in these locations, often precluding treatment with enough
doses.
Intraoperative RT (IORT) represents an opportunity to deliver
the optimal dose, or a fraction of the irradiating treatment dose to
the tumor or to the tumoral bed, while the area is being exposed
during surgical procedures.16 This approach yields higher doses
than conventional RT treatments while diminishing dose-volume
parameters through surrounding organs. Thus, it is a promising
technique to compose multimodal treatments involving surgery
and radiation. The effectiveness and safety of IORT has been pre-
viosuly reported in a range of tumor types and primary sites,
such as rectal cancer,17 retroperitoneal sarcoma,18,19 pancreatic
cancer,20 early breast cancer,21 and selected gynaecologic22 and
genitourinary tumors.23 However, the use of IORT for STS of dis-
tal extremities has been discreetly reported, and just a few studies
had discribed the use of IORT as an exclusive modality of radia-
tion, once most reports involve external-beam RT either pre- or
postoperatively.24 In addition, the majority of studies describes
IORT through the use of either electrom-beam or brachyther-
apy, which are known to have technical differences between
them.
Thus, we sought to report our experience with multimodal treat-
ment in three cases of distal extremity STS, encompassing free
surgical margins, IORT and immediate reconstruction.
2. Case-reports
2.1. Case 1
70-year-old woman, who initially presented with a soft-tissue
lesion on the dorsum of her left foot with rapid growth. She was
submitted, in May  2018, to an excisional biopsy of the lesion,
consistent with a high-grade undifferentiated pleomorphic sar-
coma. The patient had an indication for the amputation of her
left foot and asked for a second opinion. Staging exams showed
no evidence of distant metastases. Magnetic resonance imaging of
the left foot showed changes in the tumor bed consistent with
the previous biopsy. However, on clinical examination, a small
subcutaneous lesion adjacent to the surgical scar was  apprecia-
ble. Her case was discussed on a multidisciplinary tumor board
where a central pathology review was requested, as well as the
following treatment planning: oncologic surgical procedure with
intraoperative analysis of the pathology (frozen section) com-
bined with + IORT and + immediate reconstruction. The report of
the central pathology review showed a high-grade pleomorphic
undifferentiated sarcoma. In June 2018, the recommended proce-
dures were carried out. The final pathology examination revealed
a residual deposit of undifferentiated pleomorphic sarcoma of
1.0 cm,  resected with negative margins. Immunohistochemistry
showed an AE1/AE3 cytokeratin negative, negative smooth mus-
cle actin, CD68 positive, CD34 negative, EMA  negative, Ki-67 80%,
S-100 negative, vimentine positive, desmin negative. There was a
residual tumor focus of 1.0 cm on the skin. The margins were free.
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he patient undergoes the surgery in the operating room, is trans-
erred to the RT room, receives irradiating treatment, then returns
o the operating room for the surgery to be completed. This proce-
ure has already been published by our group in the IORT scenario
or 152 breast-cancer patients, and we  did not have any cases of
erioperative infection.25 We prescribed 18 Gy of dose, and used
sual collimators (instead of specific collimators for IORT) with a
erpendicular incidence to the tumor bed, and adapted customized
errobend collimation (coupled to the collimator) to the tumor bed
esign, preventing the field light (50% isodose) from reaching the
kin. The depth was estimated at 1 cm of the surgical bed surface,
ased on preoperative magnetic resonance imaging (in addition to
he 5 mm  sterile silicone bolus that had been interposed before the
ose delivery). We  chose 6 MeV  as the electron beam energy for
he treatment, at 90% isodose level. As a reconstructive technique,
 sural pedicled flap was  used. The patient evolved with epider-
olysis and partial flap loss, requiring flap debridement, and final
losure of the defect with a free graft. The current follow-up of
he patient is 24 months, with full functionality of the left foot,
ithout evidence of local or distant disease. She was  not given
ost-operative chemotherapy. Picture 1 illustrates treatment steps.
.2. Case 2
57-year-old man  who sought medical attention due to a lesion
n the dorsum of his right foot, initially evaluated as a “lipoma”.
e noticed an increase in the lesion and had difficulty putting on
is shoes. He again sought care in September 2018, and imaging
ests and a tru cut biopsy were requested. Magnetic resonance
maging showed a 5.9 × 2.0 × 5.0 cm lesion with no cleavage planes
ith halux extensor muscles and tendons. Biopsy showed low
rade myxoid sarcoma. The patient initially had an indication for
mputation of the right foot, and sought our service for a second
pinion. Staging exams had shown no evidence of distant dis-
ase. Pathology review revealed grade II mixofibrosarcoma. His
ase was discussed at a multidisciplinary tumor board where onco-
ogic surgery was proposed, with intraoperative analysis of the
athology (frozen section) combined with + IORT and + immediate
econstruction. In November 2018, the recommended procedures
ere carried out. The final examination of the pathology revealed
 grade II mixofibrosarcoma. Immunohistochemistry showed a
mooth muscle actin negative, caldesmon positive, CD10 posi-
ive, CD34 negative, desmine negative, Ki-67 20%, S-100 negative,
imentin positive. The margins were free. The IORT was carried
ut with the same specifications as the procedure performed
n case 1. We  prescribed an 18 Gy dose with a 6 MeV  electron
eam +5 mm sterile bolus at 90% isodose level, systematically
ith the same technique as described in case 1. As a recon-
tructive technique, microsurgical anterolateral cutaneous free
ap was used. The patient evolved favorably. The current follow-
p of the patient is 20 months, with full functionality of the
ight foot, with no evidence of local or distant disease. No sys-
emic treatment was  prescribed. Picture 2 shows the treatment
teps.
.3. Case 3
62-year-old man  who  sought medical care reporting a lump at
he infero-lateral aspect of his left leg for 1 year, becoming more
vident, reddish and elevated after local trauma 2 months previ-
usly. In August 2019, an excisional biopsy was performed, which
evealed a 1.7 cm grade-III mixofibrosarcoma with positive mar-
ins, confirmed at a centralized pathology review (S-100 negative,
mooth muscle actin negative, Ki-67 70%, CD34 positive, CD68 pos-
tive). He sought care at our institution where sataging images
howed no signs of distal metastasis. Local magnetic resonance













Picture 1. a) initial presentation; b) post-excision biopsy; c) Axial-STIR view of m
margin-widening; f) electrom-beam positionning; g) after immediate reconstructio
imaging suggested no signs of residual disease. The therapeutic pro-
posal was discussed at a tumor board session, and the patient was
submitted to a marginal resection with intraoperative margin con-
trol (frozen section) followed by IORT (18 Gy was prescribed with
an electron beam of 6 MeV  +5 mm sterile bolus, at 90% isodose level,
systematically following the same technique as described in case
1) and immediate reconstruction with a skin-free graft in October
2019. The final examination of the pathology confirmed a residual
high-grade myxofibrosarcoma affecting the skin, dermis, subcu-
taneous tissue and soft tissues (fascia). The patient evolved with
partial graft loss, and is currently (10 months) in the final phase of
wound closure by second intention. In spite of this, patient’s left
leg is fully functional. No systemic treatment was  recommended.




921c resonance imaging on the centre of scar; d) surgical plannings; e) after surgical
. Discussion
We presented three cases of patients with soft tissue sarcomas
f distal extremities where the association of marginal surgical
esection, IORT and immediate plastic reconstruction allowed to
omplet the whole treatment in one go, with aesthetic and func-
ional preservation and locoregional control during the period of
ollow-up achieved until now. In our view, considering the difficul-
ies of obtaining adequate surgical margins, the risks associated
ith pre- and post-operative radiotherapy techniques and the
eed for elaborate plastic reconstructions, makes this strategy a
easonable option for the treatment of distal extremity high grade
TS.
Radiation therapy plays an important role in the local con-
rol of extremities STS. Limb-sparing surgery with postoperative
S.A. Hanna et al. Reports of Practical Oncology and Radiotherapy 25 (2020) 919–926
er surgPicture 2. a) axial-T1 post-contrast MRI  view; b) surgical borders’ delineation; c) aftexternal-beam RT7,12 or interstitial brachytherapy11 resulted in
similar disease-free survival and overall survival rates when com-




922ical procedure; d) electrom-beam positionning; e) after immediate reconstruction.igh likelihood of salvage second local treatment (new conservative
pproach, or amputation) in patients who have local-recurrence
fter an initial conservative treatment. Several issues may affect














Picture 3. a) Presentation after excisional biopsy; b) after marginal surgical resect
interposition.
oncologic effectiveness, such as tumor size, margin status, exten-
sion of resection, tumor location, patient age, tumor grade and
receipt of RT, among others.26,27
Toxicity rates following postoperative RT for STS – such as
cellulitis, neuritis, fibrosis, pathologic fractures, wound compli-
cations, radiation dermatitis, edema – are frequent, occurring in
10 to 40% of the cases.28,29 The number, severity, duration, and
timing of complications are directly related to some variables,
such as patient’s comorbidities, type of RT,30,31 receipt of systemic
treatments, among others. In an attempt to reduce toxicity, a sem-
inal study from Canadian researchers32 randomized 200 patients
to preoperative RT (50 Gy in 5 weeks) versus postoperative RT
(66 Gy in 33 fractions). After a median follow-up of 3.3 years, they
found 35% and 17% of wound compliations, respectively. How-
ever, fibrosis and edema were both higher in the second arm.
As their local control rates were of no difference, the findings of






923) wet gas placement + occlusive dressing; d) Radiation beam set-up; e) after graft
Due to the assumption that toxic effects may  be related to the
ntensity of the RT dose, some attempts to de-escalate the dose,
nd to decrease the gross treatment area, in addition to the use
f combined treatment methods have been studied. Among them,
ORT appears to be an interesting option because the treatment is
elivered in a single dose, in a lower target-volume than in other
odalities of RT, and because of the possibility of physically mov-
ng away adjacent organs at risk that would not tolerate tumoricidal
adiation. In addition, this technique involves logistical and other
otentially beneficial issues - the patients receive surgery and RT in
he same time, enabling them to return to their life more quickly,
nd also allowing the use of immediate plastic reconstruction fea-
ures that will not suffer the effects of postoperative RT.
The main indication for IORT in the scenario of extremity
TS is the composition of IORT with external-beam treatments
either pre- or postoperative RT).33,34,35,39 Delivery methods
nclude electrom-beam, and brachytherapy – flexible applicators or
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a tendency towards lower toxicity rates when IORT was incorpo-
rated, due to the decrease in the dose used with external-beam
RT.40 Even in cases treated with preoperative RT (whose doses were
not purposely decreased), the use of IORT seemed to be advan-
tageous in terms of toxicity,41 but there is no level I evidence to
support this hypothesis. Nonetheless, there is scarce evidence that
only IORT is used in the management of STS.39
Patients with STS affecting distal extremities (wrist, hand, ankle,
foot) are underrepresented in the main studies that dictate the main
treatment guidelines. There are some assumptions why recom-
mendations generally followed to treat a thigh tumor, for example,
cannot actually be applied in such distal locations:
1) There is little m̈arginf̈or healthy structures to obtain an ideal
and conservative oncological surgery while maintaining func-
tionality of the extremity.42 Amputation or disarticulation rates
in these regions are quite higher probably due to this fact.
2) External-beam RT at these regions might be more difficult to
tolerate (compared to the proximal parts of the limbs). Patients
have more pain, and treatment interruptions are more frequent.
3) Brachytherapy is not recommended in regions very close to ten-
dons, nerves or bones, without m̈inimalm̈uscle tissue or fat.
Complications will become very high.
4) Preoperative RT, even if done in its entirety, may  lead to high
surgical wound complication rates and higher than the average
of the main studies.
5) Reconstructive methods are more likely to complicate in these
regions, especially when using free grafts in previously irradi-
ated areas.
Thus, patients with STS in distal extremities might benefit from
conservative approaches that include surgery with m̈inimallyf̈ree
margins - and confirmed by frozen biopsy - followed by IORT and
immediate reconstruction. These patients should be followed more
often than they used to be, seeking to detect an early recurrence and
be treated properly, without having a major impact on the natural
history of their disease.
In all three cases, the surgeries were performed in the main oper-
ating room and patients were transferred to the RT room, received
irradiating treatment and then returned to the operating room
for the plastic reconstruction to be performed. This procedure has
already been published by our group in the IORT scenario for breast
cancer,23 where we did not have any cases of perioperative infec-
tion. Also in our experience (both in cases of breast cancer and in our
3 patients from this study), our group observed that the transit of
the patient between the 2 rooms generated an average increase of
30 min  in the surgery, when compared with our patients who  were
not submitted to IORT. Therefore, the investment in a dedicated
linear accelerator for IORT has become less justifiable in our institu-
tion. Nevertheless, the use of this strategy (IORT without the need
for a dedicated linear accelerator) can be replicated in a greater
number of institutions, provided that due care is taken in steriliza-
tion, and that there is assistance from the hospital infection control
team.
In our STS patients, we decided to prescribe doses of 18 Gy, based
on the linear-quadratic model of bioequivalence.43 Eighteen-gray
delivered in single-dose would be equivalent to a conventional frac-
tionation treatment with doses of 50 Gy in terms of tumor control
– assuming alpha-beta ratio of 10 Gy, the biologically equivalent
dose (BED) is 50.4Gy10, and dose equivalent to 2 Gy (EQD2) is 42 Gy.
In terms of toxicity this ecquivalence would reach 75 Gy – taking
alpha-beta ratio of 3 Gy, the BED is 126 Gy3, and EQD2 is 75.6 Gy.
It is important to note that dose equivalence models use concepts
based on radiobiology, but uncertainties may  be taken into account
regarding the prediction of effectiveness and / or toxicity when
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These uncertainties could support an increased risk of late tox-
city when using isolated IORT (compared to IORT + EBRT), but in
act there is not much evidence to draw clear conclusions in this
egard. This was one of the reasons why we chose the 18 Gy  dose
evel. Undoubtedly, our study differs from other publications. For
nstance, in a Japanese series, Matsumine et al.38 treated 5 patients
ith STS of distal extremities in a tumor bed necessarily contain-
ng tendons. The doses varied between 25 and 50 Gy with electron
eams. No severe toxicities were observed in the follow-up of these
atients. On the other hand, in a series involving 53 patients treated
xclusively with IORT (that is, without associated pre- or postop-
rative external-beam RT), the authors45 used doses ranging from
.5–12.5 Gy. Local control rates were acceptable, and toxicity rates
ere not reported.
In fact, the actual tolerance of the extremity structures to radi-
tion is unclear because of some uncertainties, such as the lower
xygen perfusion of the body’s extremities, the alteration of the
ellular microenvironment in a post-surgical stress/trauma con-
ition, and the influence of interposition of plastic reconstruction
mmediately after the administration of the irradiating dose. Some
nimal46,47 and pre-clinical models indicate that the tolerance
f some normal tissues to high doses of radiation: nerves up to
0 Gy, muscles can tolerate before fibrosis up to single doses of up
o 50 Gy,48 and tendoms and bones usually receive single-doses
f up to 30 Gy without several necroses.38 However, clinical evi-
ence indicates otherwise. For instance, the risk of neuropathy will
ncrease when the IORT dose exceeds 15 Gy.49
Neuropathy in fact will be the most impairing-toxicity due to its
otential to generate pain and, therefore, lead to a decrease in the
uality of life. Nonetheless, we believe that the risk of neuropathy
hould be taken into account when we  speak of a p̈eripheraln̈erve
instead of a ẗrunkn̈erve, e.g., sciatic nerve). These aspects were
iscussed with the multidisciplinary team, as well as the patients
efore they underwent the treatment. In other words, we  balanced
he use of IORT as monotherapy - a minimally adequate dose for
ancer control while yielding the risk of neuropathy in the pre-
erved limb.
In our 3 cases, we had favorable outcomes in terms of healing
nd completion of immediate reconstruction in case 2. Cases 1, and
 required the 2nd surgical procedure (case 1) or wound closure
y second intention (case 3). It is not possible to correlate wound
ealing issues or complications in immediate reconstruction with
ORT because we did not have a control group for comparisons. One
f the possible causes (or contribution) of wound healing issues
ould be an eventual irradiation of the skin at the edge of the
umor bed; however, we  were careful not to allow more than 50%
f the dose to reach this region, through the individualized colli-
ation we placed in each case. Moreover, after IORT delivery, a
mall margin of the skin was  additionally removed before recon-
truction procedures. In addition, the choice of graft instead of a
ap (microsurgical or pedicled) may  have contributed to this out-
ome. Some studies suggest that the use of systemic therapies,
he combination of preoperative RT with IORT, vascular involve-
ent, or the choice of grafts may  prolong the healing period.50–53
he radiation damage will include DNA mutation in the surgical
ed, leading to double-strand breaks, and free-radical production
t cell microenvironment. The inflammation pathways by gener-
tion of cytokines, transendothelial migration of leukocytes, mast
ells, and neutrophil signaling activation will undoubtdedly make
raft adherence difficult, especially in hypovascularized regions, in
ddition to microvascular damage. Therefore, perhaps the choice of
aps – with äctivev̈ascularization – hypothetically generates better
hances for reconstruction to be integrated.
Our experience is small, but the purpose of these reports was
o illustrate the conservative therapeutic planning carried out by a
ultidisciplinary team, involving various therapeutic modalities.
S.A. Hanna et al. 
So far, patients’ follow-up is short – 24, 20, and 10 months – but
encourages us to continue deciding in a multidisciplinary discus-
sion on the best approaches for patients affected by STS of distal
extremities. One last detail to mention is the fact that - like our
case series on IORT in breast cancer - no patient had a peri-hospital
infection. It gives us confidence in performing these procedures.
This strategy can be replicated in other RT centers, as long as the
recommendations for cleaning and sterilizing surgical and hospital
environments are respected.
4. Conclusions
Even though our patients need further follow-up to consolidate
the effectiveness and safety of this strategy, we might infer from
a small experience of 3 cases that the multidisciplinary proposal
for conservative surgery with free margins, IORT and immediate
reconstruction in patients suffering from STS from distal extrem-
ities allowed for limb-preserving approaches. Strategies like this
should be encouraged and become the subject of robust studies.
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